Using AI in addiction medicine could be particularly risky

• by Steve D. Klein

• May 14, 2026

Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial

• by Peter S. Hendricks, Sara N. Lappan, Richard C. Shelton, Adrienne C. Lahti, Karen L. Cropsey, Matthew W. Johnson, Melissa Bradley, Otto Simonsson, Lori L. Davis, Daniel H. Grossman, Cynthia E. Ortiz

• May 7, 2026

Fentanyl Is Not a WMD

• by Siddharth Dave, Peter A. Goldstein

• May 6, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• May 29, 2026

• 3 min